Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Network Comparison Type Value Type Interaction Map Filtered green network_comparison red
Results: HTML CSV LaTeX Showing element 451 to 500 of 16578 in total 
Value Type: Measured
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
red\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
113\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
monocarboxylate transporter 1 (mct 1). [source:swissprot;acc:p53985]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
11206.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
858.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10348.5\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
114\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinases regulatory subunit 1 (cks-1) (sid1334) (pnas-16 / pnas-143). [source:swissprot;acc:p33551]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
11466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2302.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
13768.2\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
huntingtin interacting protein c. [source:refseq;acc:nm\_012272]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
5807.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.35048\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4300.47\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
monocarboxylate transporter 2 (mct 2). [source:swissprot;acc:o60669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
11204.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
857.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10346.9\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
115\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
monocarboxylate transporter 3 (mct 3). [source:swissprot;acc:o95907]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
11198.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
856.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10341.7\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pnas-18. [source:sptrembl;acc:q9bzu3]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11409.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2270.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
13680.5\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
116\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amino acid transporter xat2; likely ortholog of mouse aspartate/glutamate transporter 1 (agt1). [source:refseq;acc:nm\_138817]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
856.67\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 1 (ralgds-like 1). [source:swissprot;acc:q9nzl6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
11017.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2244.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
13261.9\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
117\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
metalloprotease 1; metalloprotease 1 (pitrilysin family). [source:refseq;acc:nm\_014889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7090.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2186.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
9276.47\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
y+l amino acid transporter 1 (y(+)l-type amino acid transporter 1) (y+lat-1) (y+lat1) (monocyte amino acid permease 2) (mop-2). [source:swissprot;acc:q9um01]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
856.67\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
118\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-1,4 mannosyltransferase. [source:refseq;acc:nm\_019109]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7089.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2185.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
9275.1\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cystine/glutamate transporter (amino acid transport system xc-) (xct) (calcium channel blocker resistance protein ccbr1). [source:swissprot;acc:q9upy5]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
856.67\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
necdin. [source:swissprot;acc:q99608]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
119\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, very-long-chain specific, mitochondrial precursor (ec 1.3.99.-) (vlcad). [source:swissprot;acc:p49748]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
15138.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2139.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
12998.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6. [source:refseq;acc:nm\_003983]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
856.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}}\\\cline{1-2}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
120\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4b (eif-4b). [source:swissprot;acc:p23588]\vspace{3pt}}&&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6895.98\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34247\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5136.78\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
proto-oncogene protein c-fos (cellular oncogene fos) (g0/g1 switch regulatory protein 7). [source:swissprot;acc:p01100]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2101.02\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
121\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
b(0,+)-type amino acid transporter 1 (b(0,+)at) (glycoprotein- associated amino acid transporter b0,+at1). [source:swissprot;acc:p82251]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
856.67\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
jun dimerization protein. [source:refseq;acc:nm\_130469]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7033.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2101.02\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4932.27\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor jun-b. [source:swissprot;acc:p17275]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
7488.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.3422\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5579.18\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
122\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
7037.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2095.16\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4941.95\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
6893.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.34112\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5140.14\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
monocarboxylate transporter 4 (mct 4) (mct 3). [source:swissprot;acc:o15427]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
11178.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
853.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10325\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
123\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33503\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein fosb (g0/g1 switch regulatory protein 3). [source:swissprot;acc:p53539]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7037.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2094.83\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4942.49\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
transmembrane protein tmp21 precursor (21 kda transmembrane trafficking protein) (p24delta) (s31iii125) (s31i125) (tmp-21-i). [source:swissprot;acc:p49755]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12252.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
849.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11403\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
124\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7038.04\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2093.74\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4944.3\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol glycan, class b. [source:refseq;acc:nm\_004855]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12252.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
849.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11403\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
125\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14561.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2090\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
12471.7\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10318.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0937\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11285.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.33501\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
septin 2 (nedd5 protein homolog). [source:swissprot;acc:q15019]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10996.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
828.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10168.5\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/